Dextran 40 10% + Sodium Chloride 0.9%

Welcome to Dwaey, specifically on Dextran 40 10% + Sodium Chloride 0.9% page.
This medicine contains important and useful components, as it consists of
Dextran 40 10% + Sodium Chloride 0.9% is available in the market in concentration.

Generic Name of Dextran 40 10% + Sodium Chloride 0.9% - Learn More

Dextran 40 10% + Sodium Chloride 0.9%

Dextran 40 10% + Sodium Chloride 0.9% Precaution - What You Need to Know

Dextran 40 10% combined with Sodium Chloride 0.9% is primarily used for volume expansion and fluid resuscitation in patients with hypovolemia, particularly after blood loss or in states of shock. Caution is needed in patients with a history of hypersensitivity to dextran or sodium chloride, as allergic reactions can occur, ranging from mild rashes to more severe anaphylaxis. The combination should be used carefully in patients with pre-existing cardiovascular conditions such as heart failure, as it may lead to fluid overload, worsening edema, or increased blood pressure. In renal impairment, especially in patients with reduced kidney function, this combination may exacerbate fluid retention and electrolyte imbalances. For patients with pulmonary edema or other conditions where fluid retention is undesirable, the volume expansion effect should be carefully monitored. For pregnant and breastfeeding women, Dextran 40 10% + Sodium Chloride 0.9% should only be used when necessary, as there is limited safety data available, and the drug’s components can pass through the placenta and into breast milk. Additionally, sodium chloride should be used cautiously in individuals with hypernatremia or those on sodium-restricted diets due to the sodium content, which may contribute to electrolyte disturbances. Close monitoring of electrolytes, fluid balance, and vital signs is necessary when using this solution in these populations.

Dextran 40 10% + Sodium Chloride 0.9% Indication - Uses and Benefits

Dextran 40 10% + Sodium Chloride 0.9% is indicated for the treatment of hypovolemia, particularly in patients suffering from acute blood loss, dehydration, or shock. The dextran component acts as a plasma expander, helping to restore circulatory volume and improve blood pressure by drawing fluid into the bloodstream through its osmotic properties. The sodium chloride component serves as a crystalloid solution that provides essential electrolytes and helps maintain osmotic balance in the body. This solution is used in emergency settings, particularly in critical care units, to restore plasma volume and maintain perfusion to vital organs. It is also used in surgeries, trauma care, and other medical interventions where significant fluid loss occurs. Off-label uses include support in conditions that require volume expansion, such as during dialysis or for managing fluid imbalances in patients who have undergone extensive burns or other major surgeries. The combined solution is not intended to replace blood transfusions but may be used when blood loss is not severe enough to require transfusion.

Dextran 40 10% + Sodium Chloride 0.9% Contraindications - Important Warnings

Dextran 40 10% + Sodium Chloride 0.9% is contraindicated in patients with known hypersensitivity to dextran, sodium chloride, or any other components of the solution. It should not be used in individuals who are at risk of fluid overload or who have pre-existing conditions such as congestive heart failure, renal failure, or pulmonary edema, as the solution can exacerbate these conditions by increasing circulatory volume. Additionally, this solution is contraindicated in patients with hypernatremia or those on a sodium-restricted diet, as the sodium chloride content may worsen electrolyte imbalances. In patients with severe dehydration, where the primary issue is a lack of water rather than volume, the use of a hypertonic solution like this one may worsen dehydration, and alternative treatments should be considered. This combination should also not be used in cases where there is a risk of bleeding disorders or thrombosis, as dextran has been linked to transient changes in coagulation parameters and may contribute to bleeding risk. It is also contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), as it can exacerbate renal failure and cause further fluid retention.

Dextran 40 10% + Sodium Chloride 0.9% Side Effects - What to Expect

The side effects of Dextran 40 10% + Sodium Chloride 0.9% are generally related to the volume expansion and sodium content. The most common adverse effects include hypersensitivity reactions, which can manifest as rash, pruritus, fever, or in rare cases, anaphylaxis. Fluid overload is a significant concern, especially in patients with underlying cardiovascular or renal conditions, and may lead to edema, shortness of breath, or increased blood pressure. The sodium chloride component may contribute to hypernatremia, especially in patients with compromised renal function or those on sodium-restricted diets. Overuse can lead to electrolyte imbalances, such as hypokalemia or hyponatremia, with symptoms including muscle weakness, confusion, and arrhythmias. Transient effects on coagulation, such as prolonged bleeding times, can occur due to dextran’s impact on platelet function. This can increase the risk of bleeding, especially in patients undergoing surgery or receiving anticoagulants. Prolonged administration may also cause changes in liver function or transient increases in liver enzymes. Monitoring of vital signs, renal function, electrolytes, and coagulation parameters is necessary to mitigate the risk of serious side effects.

Dextran 40 10% + Sodium Chloride 0.9% Pregnancy Category ID - Safety Information

3

Dextran 40 10% + Sodium Chloride 0.9% Mode of Action - How It Works

Dextran 40 10% + Sodium Chloride 0.9% acts primarily by restoring plasma volume and improving circulatory function in patients experiencing hypovolemia. The dextran component is a high-molecular-weight polysaccharide that increases the osmotic pressure of the blood, helping to draw fluid from the interstitial space into the intravascular space, thereby expanding blood volume and improving perfusion. The dextran molecules stay within the vascular compartment for a longer duration than crystalloids, offering prolonged plasma volume expansion. Sodium chloride, a balanced electrolyte solution, helps maintain osmotic pressure, regulate fluid distribution between compartments, and restore electrolyte balance. The sodium content also helps maintain blood pressure and ensures proper nerve and muscle function by stabilizing extracellular fluid volume. This combination provides a short-term solution for acute volume resuscitation, helping to stabilize patients and ensure that vital organs receive adequate blood supply. The synergy between the plasma-expanding effects of dextran and the osmotic balance provided by sodium chloride ensures effective treatment in hypovolemic states.

Dextran 40 10% + Sodium Chloride 0.9% Drug Interactions - What to Avoid

Dextran 40 10% + Sodium Chloride 0.9% may interact with various medications, particularly those affecting fluid and electrolyte balance. When administered alongside diuretics, the combination can cause electrolyte imbalances, such as hyponatremia or hypokalemia, requiring careful monitoring and dose adjustments. The dextran component may interfere with anticoagulant therapies, especially heparin, as it can influence platelet function and prolong bleeding times. Patients on insulin or oral hypoglycemic agents should be monitored closely for hyperglycemia due to the dextrose component in the formulation. In patients receiving corticosteroids or other medications that increase sodium retention, such as certain antihypertensives, the risk of fluid retention and sodium overload is increased. Furthermore, the solution should not be administered concurrently with blood products, as it may cause compatibility issues or impair the function of red blood cells. When used in conjunction with other intravenous solutions containing calcium or magnesium, careful attention should be paid to potential precipitate formation, as the presence of different ions may destabilize the solution. Therefore, careful review of the patient’s medication list and fluid status is essential before administering this solution.

Dextran 40 10% + Sodium Chloride 0.9% Adult Dose - Recommended Dosage

For adult patients, the initial dosage of Dextran 40 10% + Sodium Chloride 0.9% typically depends on the severity of fluid loss and clinical indications. The usual infusion rate is 10–20 mL/kg body weight over the course of 30–60 minutes for the initial resuscitation phase, with additional doses based on patient response. This dose may be repeated or adjusted according to the patient’s fluid needs, clinical status, and response to therapy. In critical situations such as shock, larger volumes may be administered initially, followed by slower infusion rates to maintain blood volume. The maximum daily dose is usually up to 2 liters, but this can vary based on the patient's condition. Infusion rates should be closely monitored to avoid fluid overload or electrolyte imbalances, particularly in those with renal or cardiovascular conditions. Blood pressure, electrolytes, and other vital signs should be monitored regularly to guide appropriate dosing adjustments.

Dextran 40 10% + Sodium Chloride 0.9% Child Dose - Dosage for Children

In pediatric patients, Dextran 40 10% + Sodium Chloride 0.9% is used cautiously for volume expansion in critical care situations such as shock or severe dehydration. The typical starting dose is 10–20 mL/kg body weight, administered intravenously over 30 minutes to 1 hour. Dosing may be repeated based on the patient’s clinical status and fluid requirements. In neonates and infants, the solution should be used with great care due to the potential for fluid overload, and administration rates should be lower compared to older children. Careful monitoring of vital signs, fluid balance, electrolytes, and blood glucose levels is essential during treatment. Close attention should also be paid to the risk of hypernatremia, especially in preterm infants or those with renal impairment. Pediatric patients are more susceptible to complications related to fluid balance, and individualized dosing and monitoring are key to minimizing adverse effects.

Dextran 40 10% + Sodium Chloride 0.9% Renal Dose - Dosage for Kidney Conditions

In patients with renal impairment, Dextran 40 10% + Sodium Chloride 0.9% should be used with caution due to the risk of fluid overload and electrolyte disturbances. In those with mild to moderate renal dysfunction (creatinine clearance >30 mL/min), no specific dose adjustment is necessary, but close monitoring of renal function, fluid balance, and electrolytes is essential. In patients with severe renal failure or end-stage renal disease, this combination should generally be avoided, as it may exacerbate fluid retention, leading to worsening renal function. If the solution is used in such patients, careful dosing adjustments and close monitoring of urine output, renal function, and electrolytes are critical. In these cases, hemodialysis or other renal replacement therapies may be required to manage fluid overload and maintain proper electrolyte balance.